Stock Rally Peters Out After Vaccine Euphoria: Markets Wrap, , on November 10, 2020 at 7:23 am

Financial News
By
On November 10, 2020
In Financial News
Tags:

(Bloomberg) — A rally in global stocks stalled in Asian trading Tuesday amid concern that a promising coronavirus vaccine study still has hurdles to clear. Bonds and other haven assets steadied after overnight declines.Shares pared gains in Japan, Hong Kong and Australia, while Chinese stocks fell. S&P 500 futures fluctuated and European contracts dipped. Risks such as the outlook for fresh U.S. fiscal stimulus, surging coronavirus cases and legal challenges to the U.S. election outcome also weighed on sentiment.Earlier, the S&P 500 closed at a two-month high on news the coronavirus shot being developed by Pfizer Inc. and BioNTech SE prevented over 90% of infections. The Nasdaq 100 fell as investors rotated out of defensive technology names into shares depressed by the economic impact of lockdowns.Yields on 10-year Treasuries traded around their highest since March. A measure of credit-market risk eased to pre-pandemic levels, and U.S. junk-bond yields fell to a record low. The dollar slipped. Gold and the Japanese yen pared some of Monday’s losses.Investors pulled out of defensive assets and poured cash into markets that are closely tied to economic growth in the immediate aftermath of the vaccine news. The top infectious disease expert in the U.S., Anthony Fauci, said the shot being developed by Pfizer will have a “major impact” on everything we do with regards to Covid-19 going forward.Separately, an antibody therapy from Eli Lilly & Co. was granted emergency-use authorization in the U.S. But the final-stage trial of a frontrunner Chinese vaccine candidate was halted in Brazil due to a serious adverse event. Experts cautioned questions remain to be answered before an inoculation can be rolled out.“There are obvious questions about the sustainability of positive vaccine news flows – from efficacy, to scalability, to side effects, to distribution/refrigeration issue,” said Michael Purves, chief executive officer at Tallbacken Capital Advisors LLC.The U.S. surpassed 10 million Covid-19 cases on Monday and appeared poised to hit record hospitalizations later this week. President-elect Joe Biden warned the nation faced a “dark winter” and announced a new coronavirus task force as his transition team seeks to fulfill a campaign promise to contain the outbreak.The Federal Reserve warned that asset prices in key markets could take a hit if the pandemic’s economic impact worsens in coming months.These are some key events coming up:Alibaba holds its annual Singles’ Day on Wednesday, an online global shopping phenomenon that had $38 billion of sales last yearEuropean Central Bank President Christine Lagarde, Bank of England Governor Andrew Bailey and Federal Reserve Chair Jerome Powell are among the speakers Thursday at an online ECB Forum entitled “Central Banks in a Shifting World”Finance ministers and central bankers from the Group of 20 hold an extraordinary meeting Friday to discuss bolder action to help poor nations struggling to repay their debts.These are some of the main moves in markets:StocksS&P 500 futures rose 0.1% as of 7:18 a.m. in London. The S&P 500 rose 1.2%.Topix index climbed 1.1%.S&P/ASX 200 Index gained 0.7%.Kospi index fluctuated.Hang Seng Index rose 0.8%.Shanghai Composite Index fell 0.4%.Euro Stoxx 50 futures slid 0.2%.CurrenciesThe yen was at 105.10 per dollar, up 0.3%.The offshore yuan was at 6.6058 per dollar, up 0.2%.The Bloomberg Dollar Spot Index dipped 0.1%.The euro traded at $1.1827, up 0.1%.BondsThe yield on 10-year Treasuries was at 0.93%.Australia’s 10-year bond yield jumped 15 basis points to 0.92%.CommoditiesWest Texas Intermediate crude rose 0.3% to $40.40 a barrel.Gold rose 1.3% to $1,888.27 an ounce.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.,

Stock Rally Peters Out After Vaccine Euphoria: Markets Wrap(Bloomberg) — A rally in global stocks stalled in Asian trading Tuesday amid concern that a promising coronavirus vaccine study still has hurdles to clear. Bonds and other haven assets steadied after overnight declines.Shares pared gains in Japan, Hong Kong and Australia, while Chinese stocks fell. S&P 500 futures fluctuated and European contracts dipped. Risks such as the outlook for fresh U.S. fiscal stimulus, surging coronavirus cases and legal challenges to the U.S. election outcome also weighed on sentiment.Earlier, the S&P 500 closed at a two-month high on news the coronavirus shot being developed by Pfizer Inc. and BioNTech SE prevented over 90% of infections. The Nasdaq 100 fell as investors rotated out of defensive technology names into shares depressed by the economic impact of lockdowns.Yields on 10-year Treasuries traded around their highest since March. A measure of credit-market risk eased to pre-pandemic levels, and U.S. junk-bond yields fell to a record low. The dollar slipped. Gold and the Japanese yen pared some of Monday’s losses.Investors pulled out of defensive assets and poured cash into markets that are closely tied to economic growth in the immediate aftermath of the vaccine news. The top infectious disease expert in the U.S., Anthony Fauci, said the shot being developed by Pfizer will have a “major impact” on everything we do with regards to Covid-19 going forward.Separately, an antibody therapy from Eli Lilly & Co. was granted emergency-use authorization in the U.S. But the final-stage trial of a frontrunner Chinese vaccine candidate was halted in Brazil due to a serious adverse event. Experts cautioned questions remain to be answered before an inoculation can be rolled out.“There are obvious questions about the sustainability of positive vaccine news flows – from efficacy, to scalability, to side effects, to distribution/refrigeration issue,” said Michael Purves, chief executive officer at Tallbacken Capital Advisors LLC.The U.S. surpassed 10 million Covid-19 cases on Monday and appeared poised to hit record hospitalizations later this week. President-elect Joe Biden warned the nation faced a “dark winter” and announced a new coronavirus task force as his transition team seeks to fulfill a campaign promise to contain the outbreak.The Federal Reserve warned that asset prices in key markets could take a hit if the pandemic’s economic impact worsens in coming months.These are some key events coming up:Alibaba holds its annual Singles’ Day on Wednesday, an online global shopping phenomenon that had $38 billion of sales last yearEuropean Central Bank President Christine Lagarde, Bank of England Governor Andrew Bailey and Federal Reserve Chair Jerome Powell are among the speakers Thursday at an online ECB Forum entitled “Central Banks in a Shifting World”Finance ministers and central bankers from the Group of 20 hold an extraordinary meeting Friday to discuss bolder action to help poor nations struggling to repay their debts.These are some of the main moves in markets:StocksS&P 500 futures rose 0.1% as of 7:18 a.m. in London. The S&P 500 rose 1.2%.Topix index climbed 1.1%.S&P/ASX 200 Index gained 0.7%.Kospi index fluctuated.Hang Seng Index rose 0.8%.Shanghai Composite Index fell 0.4%.Euro Stoxx 50 futures slid 0.2%.CurrenciesThe yen was at 105.10 per dollar, up 0.3%.The offshore yuan was at 6.6058 per dollar, up 0.2%.The Bloomberg Dollar Spot Index dipped 0.1%.The euro traded at $1.1827, up 0.1%.BondsThe yield on 10-year Treasuries was at 0.93%.Australia’s 10-year bond yield jumped 15 basis points to 0.92%.CommoditiesWest Texas Intermediate crude rose 0.3% to $40.40 a barrel.Gold rose 1.3% to $1,888.27 an ounce.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

+65 3105 1295

Taiwan

Coming Soon!

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Follow Us

Market Coverage